EARLY-MYO-SEPSIS Registry
EARLY-MYO-SEPSIS (EARLY Assessment of MYOcardial Injury in Sepsis Patient) Registry
1 other identifier
observational
300
0 countries
N/A
Brief Summary
The diagnosis and pathophysiology of sepsis-induced cardiac dysfunction remain unknown. This registry is to evaluate characteristics of sepsis patients by multi-modalities imaging, including echocardiography, cardiovascular magnetic resonance imaging in 300 patients in 5 sites. Subjects will be followed up to 2 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 10, 2020
CompletedFirst Posted
Study publicly available on registry
August 14, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2023
CompletedAugust 14, 2020
August 1, 2020
2 years
August 10, 2020
August 12, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
composite of death, stroke, heart failure
composite of death, stroke, heart failure
2 years
Secondary Outcomes (1)
day of hospitalization
through study completion, 2 months
Eligibility Criteria
Patients were diagnosed as sepsis or suspected as sepsis
You may qualify if:
- Patiants meets the criteria of Sepsis 3.0 as below:
- Sepsis is a lifethreatening organ dysfunction caused by a dysregulated host response to infection
- patients in ICU：
- have at least one organ dysfunction
- SOFA score ≥2
- patients not in ICU
- have at least one organ dysfunction
- SOFA score or qSOFA score ≥2
You may not qualify if:
- \. Patient who is unable to comply with the follow-up schedule.
- \. Patient who has any medical conditions that in the opinion of the investigators will not be appropriate to participate in the study.
- \. Patient has a life expectancy of less than 6 months due to any condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RenJi Hospitallead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2020
First Posted
August 14, 2020
Study Start
September 1, 2020
Primary Completion
August 31, 2022
Study Completion
August 31, 2023
Last Updated
August 14, 2020
Record last verified: 2020-08